Video Experimental Relacionado
Updated: Jan 15, 2026
04:04
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
941
Normalización de los síntomas gastrointestinales en adultos con estreñimiento con el consumo diario de kiwi verde:
Jasjot Maggo1,2, Hwei Min Ng1,2, Simone Birgit Bayer1,2
1Department of Medicine, Christchurch, University of Otago, 2 Riccarton Avenue, Christchurch, 8011, New Zealand, 64 3 244 1074.
JMIR research protocols
|January 14, 2026
Resumen
El kiwi verde puede aliviar el dolor abdominal en personas con síndrome del intestino irritable predominante en estreñimiento (SII-E) y estreñimiento funcional (EF). Este estudio exploró sus efectos y mecanismos subyacentes, ofreciendo un posible alivio natural para las molestias digestivas.
Área de la Ciencia:
- Ciencias Gastroenterológicas y Nutricionales; Investigación del Microbioma e Inmunología; Investigación Fisiológica y Clínica
Sus antecedentes:
- El síndrome del intestino irritable con estreñimiento (SII-E) y el estreñimiento funcional (EF) afectan significativamente la calidad de vida.
- Los tratamientos actuales para el SII-E y el EF presentan desafíos.
- El kiwi verde muestra promesa como una alternativa laxante natural, pero su eficacia para el dolor abdominal y sus mecanismos requieren una fundamentación.
Objetivo del estudio:
- Investigar el efecto del consumo diario de kiwi verde en el dolor y la incomodidad abdominal en personas con SII-E y EF.
- Explorar los mecanismos fisiológicos y bioquímicos subyacentes asociados con la ingesta de kiwi verde para la salud digestiva.
- Evaluar el impacto del kiwi verde en la motilidad intestinal, el microbioma y los marcadores inflamatorios.
Principales métodos:
- Un estudio aleatorizado, abierto y controlado con placebo de 9 semanas y 2 brazos que involucró a 60 participantes con SII-E y EF.
- El grupo de intervención consumió 2 kiwis verdes al día durante 4 semanas; el grupo de control consumió un placebo de maltodextrina con igual contenido calórico.
- Se utilizaron cuestionarios validados, RM para la fisiología del colon, tinte azul para el tránsito, muestras de sangre/heces y dispositivos de motilidad inalámbricos.
Principales resultados:
- El análisis de datos está completo y se esperan los resultados completos para abril de 2026.
- Se analizaron 57 participantes mediante análisis por intención de tratar.
- El estudio proporciona un conjunto de datos completo sobre los efectos fisiológicos y bioquímicos del kiwi verde en pacientes con SII-E y EF.
Conclusiones:
- El consumo de kiwi verde puede controlar eficazmente el dolor abdominal en pacientes con SII-E y EF.
- Esta investigación ofrece nuevas perspectivas sobre los mecanismos por los cuales el kiwi verde promueve la comodidad digestiva.
- Los hallazgos respaldan el kiwi verde como una opción terapéutica natural potencial para los trastornos gastrointestinales funcionales.
Videos de Conceptos Relacionados
01:21Drugs for Treatment of Constipation-Predominant IBS
712
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
712
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
727
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
727
01:17Irritable Bowel Syndrome I: Introduction
916
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
916
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
640
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
640
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
01:17Chronic Bowel Disorders: Introduction
744
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
744